1. 94PHPV circulating tumor DNA as predictive biomarker of sustained response to chemotherapy in advanced anal carcinoma. (23rd October 2018) Authors: Bernard-Tessier, A; Jeannot, E; Guenat, D; Michel, M; Proudhon, C; Vincent-Salomon, A; Bièche, I; Pierga, J-Y; Buecher, B; Francois, E; Kim, S; André, T; Jary, M; Vendrely, V; Samalin, E; El Hajbi, F; Baba-Hamed, N; Meurisse, A; Bidard, F-C; Borg, C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P-080Regorafenib combined with irinotecan as second-line treatment in patients with metastatic gastro-oesophageal adenocarcinomas: A randomized phase 2 trial (PRODIGE 58 – UCGI 35 – REGIRI). (2nd July 2019) Authors: Samalin, E; Turpin, A; Khemissa, F; Zaanan, A; Benabdelghani, M; Senellart, H; Gilabert, M; Evesque, L; Dahan, L; Sefrioui, D; Bouché, O; De la Fouchardière, C; Hennequin, A; Monard, L; Gourgou, S; Lopez, A Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P-099Triplet chemotherapy plus cetuximab as first-line treatment in RAS wild-type metastatic colorectal carcinoma patients. (2nd July 2019) Authors: Samalin, E; Mazard, T; Assenat, E; Rouyer, M; De la Fouchardière, C; Guimbaud, R; Smith, D; Portales, F; Ychou, M; Fiess, C; de Forges, H; Lopez-Crapez, E; Thézenas, S Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗